Prediction of cytogenetic abnormalities with gene expression profiles
- PMID: 22496154
- PMCID: PMC3367903
- DOI: 10.1182/blood-2011-10-388702
Prediction of cytogenetic abnormalities with gene expression profiles
Abstract
Cytogenetic abnormalities are important clinical parameters in various types of cancer, including multiple myeloma. We developed a model to predict cytogenetic abnormalities in patients with multiple myeloma using gene expression profiling and validated it by different cytogenetic techniques. The model has an accuracy rate up to 0.89. These results provide proof of concept for the hypothesis that gene expression profiling is a superior genomic method for clinical molecular diagnosis and/or prognosis.
References
-
- Barlogie B, Epstein J, Sanderson R, Anaissie E, Walker R, Tricot G. Plasma cell myeloma. In: Lichtman MA, Kaushansky K, Kipps TJ, Seligsohn U, Prchal J, editors. Williams Hematology. 7th Ed. New York, NY: McGraw-Hill; 2005. pp. 1501–1533.
-
- Kuehl WM, Bergsagel PL. Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer. 2002;2(3):175–187. - PubMed
-
- Seong C, Delasalle K, Hayes K, et al. Prognostic value of cytogenetics in multiple myeloma. Br J Haematol. 1998;101(1):189–194. - PubMed
-
- Stewart AK, Fonseca R. Prognostic and therapeutic significance of myeloma genetics and gene expression profiling. J Clin Oncol. 2005;23(26):6339–6344. - PubMed
-
- Zhan F, Hardin J, Kordsmeier B, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002;99(5):1745–1757. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
